DYAI Q1 2026 Earnings EPS Misses Mark as PreRevenue Biotech Maintains Pipeline Focus LODE Q1 2026 Earnings EPS Surpasses Estimates as Company Advances Strategic Initiatives PHIO Q1 2026 Earnings EPS Misses Estimates as ResearchFocused Biotech Maintains Development Pace CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue Tower Semiconductor Ltd TSEM Q1 2026 Earnings Robust EPS Beat Highlights Operational Discipline Amid Revenue Uncertainty Marriott International Q1 2026 Earnings EPS Beats Estimates by 546 Shares Edge Lower